|
1.9 Catch-Up Vaccination
Introduction
Not infrequently, children who present for immunisation have missed out
on previously scheduled vaccines. To ensure that these ‘overdue’ children
can be protected as quickly as possible, ‘catch-up’ vaccination schedules,
based on the ASVS, are available.
Every opportunity should be taken to check vaccination status and to
provide missing doses. When infants and children have missed scheduled
vaccine doses, a catch-up schedule should be commenced. The information and
tables below are designed to assist in planning a catch-up program based on
the ASVS.
If the vaccine provider is uncertain about how to plan the catch-up
schedule, contact either a public health professional or a paediatrician
with vaccination expertise.
An on-line ‘catch-up calculator’ is available
at
www.health.sa.gov.au/immunisationcalculator.
Vaccination with incomplete vaccination records
The most important requirement for assessment of vaccination status is to
have written documentation of vaccination. In children 7 years of age and
under, vaccination status should be available from the Australian Childhood
Immunisation Register (ACIR), unless the course of vaccines was commenced
overseas. In persons over this age, the approach of providers to the problem
of inadequate records should be based on the age of the individual, whether
the vaccines in question have been given in Australia or overseas and the
vaccines being considered for catch-up.
(i) Children 8 years of age or less
In this age group, the primary reference point should be the ACIR. If the
parent states that vaccines not recorded on the ACIR have been given, every
effort should be made to contact the provider. If confirmation from the
nominated provider or the ACIR cannot be obtained, unless other convincing
evidence of vaccination such as written records is available, children
should be offered a catch-up course of vaccination appropriate for age.
(ii) Children and adolescents 9 to 17 years
In children over the age of 8 years and adolescents, alternative sources
of documentation to the ACIR such as personal health records will be needed,
but are less likely to be available with increasing age. The relevant
vaccines for catch-up in this age group are hepatitis B, measles, mumps,
rubella (MMR), meningococcal C conjugate (MenCCV), varicella-zoster (VZV),
inactivated poliomyelitis (IPV), diphtheria, tetanus and pertussis vaccines.
For hepatitis B, MenCCV, VZV, IPV and MMR vaccines there are no adverse
effects associated with additional doses in immune individuals. In the case
of diphtheria and tetanus, additional doses are associated with a
significant increase in local and systemic reactions in immune individuals.
This means that if catch-up vaccination requiring more than one diphtheria
or tetanus containing vaccine is considered because of lack of
documentation, particular attention should be paid to the occurrence of
local or systemic reactions before proceeding with a second or third
catch-up dose.
(iii) Adults (18 years and over)
In adults, written documentation of previous vaccination history may not
be available. The main antigens where past history is important because of
the potential for adverse reactions in immune individuals are diphtheria and
tetanus. Pneumococcal polysaccharide vaccine history in the previous 5 years
is also an issue. Additional doses of MMR, VZV, IPV or hepatitis B vaccine
are rarely associated with significant adverse reactions in adults. If a
tetanus-prone wound is the reason for considering additional tetanus
vaccine, NHMRC recommends giving additional tetanus-containing vaccines if
there is any uncertainty (see
Table 3.24.1).
Interrupted vaccine doses
If the recommended intervals between doses are exceeded, there is no need
to recommence the schedule or give additional doses, because the immune
response is not impaired by such delay. If the process of administration of
vaccine is interrupted (eg. by syringe-needle disconnection or vomiting of
OPV within 10 minutes of administration) the whole dose should be repeated
as soon as practicable.
Issues to be considered when planning catch-up
vaccination
- Plan the catch-up on the basis of the available, and
preferably documented, evidence of previous vaccination.
- Vaccine doses should not be administered at less than the
minimal intervals or less than the minimum age (see
Table 1.9.1).2
- Doses administered earlier than the minimum interval or age
should not be counted as valid doses and should be repeated as
age-appropriate using the minimum interval table (see
Table 1.9.1).
- When commencing the recommended catch-up vaccination
schedule the interval between doses may be reduced or extended and the
numbers of doses required may reduce with age. For example from 15 months
of age, only one dose of (any) Hib vaccine is required.
- As a child gets older the recommended vaccines change or
they might need to be omitted from the schedule.
- For incomplete vaccination or overdue vaccinations, build on
previous documented doses. Never start the schedule again, regardless of
the interval (unless there are no written vaccination records).
- If more than one vaccine is overdue, it will often be
appropriate to give all the vaccines at one visit. In such cases, the next
visit should be scheduled for a time after the appropriate minimal
interval (eg. normally one to two months between first and second dose,
and second and third doses of DTPa-containing vaccines).
- Check rules on interchangeability of vaccines. Some vaccines
and vaccine brands are not interchangeable.
- The optimal intervals recommended in the ASVS should be used
once the child or adult is back to the recommended vaccine and dose number
for their age.
Table 1.9.1:
Minimum intervals between vaccine doses
— a guide for planning catch-up schedules
| Vaccine |
Minimum interval between doses
|
| |
Dose 1—2 |
Doses 2—3 |
Doses 3—4 |
Doses 4—5 |
DTPa (1)
DTPa-IPV |
1 month |
1 month |
6 months (6) |
NA |
DTPa-IPV-Hib
DTPa-IPV/Hib |
1 month |
1 month |
6 months (2) |
NA |
| dT (ADT) |
1 month |
1 month |
10 years |
10 years (3) |
| DT (CDT) (4) |
1 month |
6 months |
NA |
NA |
PRP-OMP
Hib (PRP-OMP)-hepB |
1 month |
2 months (5) |
NA |
NA |
| HbOC |
1 month |
1 month |
2 months (5) |
NA |
| PRP-T |
1 month |
1 month |
2 months (5) |
NA |
| OPV |
1 month |
1 month |
NA (6) |
NA |
| IPV |
1 month |
1 month |
NA (6) |
NA |
| MMR |
1 month |
NA |
NA |
NA |
Hepatitis B
DTPa-hepB
DTPa-hepB-IPV
DTPa-hepB-IPV-Hib |
1 month |
2 months (7) |
NA |
NA |
| NA = not applicable |
| (1) If possible, the same
brand of DTPa-containing vaccine should be used for the first 3
doses. If this is not possible, vaccination should be completed
with the available brand. DTPa-IPV vaccines can be interchanged
for the fourth (booster) dose. Administer all 4 doses of DTPa at
the recommended intervals in children under 8 years of age. |
| (2) The minimum interval
between the third and fourth doses is based on the DTPa
requirements. Follow the recommendations below (5) for Hib
vaccines. |
| (3) All people should be
offered a dose of either dT or adult/adolescent formulation dTpa
at 50 years of age unless a dose of either has been administered
within 10 years. |
| (4) Use DTPa or CDT until the
eighth birthday. |
| (5) Booster doses (third dose
for PRP-OMP or fourth doses for HbOC or PRP-T) are given no
earlier than the first birthday and at least 2 months after a
previous dose. If the child is aged 15 months or more, only one
dose of any brand of Hib vaccine is required. |
| (6) Preferably administer
(fourth) booster dose as DTPa-IPV at 4 years of age if required. |
| (7) A one-month interval
between doses 2 and 3 is appropriate, but only if a birth dose of
hepatitis B vaccine was given; otherwise the minimum interval
between doses 2 and 3 should be 2 months. |
|

Catch-up using acellular pertussis-containing
vaccines and dT for children and adults
Monovalent pertussis vaccine is not available in Australia. Therefore any
necessary pertussis catch-up vaccination can only be undertaken with either
DTPa or DTPa-containing combination vaccines.
Catch-up for DTPa vaccines in children under 8
years of age
If a child has received previous doses of DT, then DTPa or DTPa
combinations can be used for catch-up
provided that no more than 6 doses of diphtheria and tetanus toxoids
are given in total. An excessive number of total doses may increase the risk
of severe local reactions.
With the introduction of a 4-dose DTPa schedule on the ASVS:
- children under 8 years of age require 3 doses of DTPa, or
DTPa-combination vaccines that do not contain hepatitis B, at a minimum
interval of 4 weeks between doses to complete the primary series (see
Table 1.9.1).
- if children under 8 years of age are given a
DTPa-combination vaccine that contains hepatitis B for catch-up then there
should be a minimum interval of 2 months between doses 2 and 3 if no birth
dose of hepatitis B vaccine was given (Table
1.9.1).
- a fourth (booster) dose, usually given as DTPa-IPV, should
be given at 4 years of age or 6 months after the third dose, whichever is
later.
Catch-up using dT (ADT) in those 8 years of age
and over, and the use of adult/adolescent formulation dTpa vaccine for
boosters
Using dT (ADT) vaccine
The minimum age for using dT (ADT) or tetanus toxoid (TT) is 8 years of
age. Those aged 8 years and older who do
not have a documented history of a primary series (ie at least 3
doses of DTP, DTPa or DTPa-combination vaccine) should be given the missing
doses as dT (ADT) with a minimum interval of one month between the doses.
Adults over 17 years of age who have only received 3 doses of DTP or
dT-containing vaccines require a further two booster doses at a minimum
interval of 10 years.
All people should be offered the routine booster dose of dT (ADT) vaccine
at 50 years of age unless a dose has been administered within the previous
10 years. The adult/adolescent formulation dTpa (Boostrix) can be used at 50
years of age instead of ADT, provided that no prior doses of dTpa have been
administered (see
Part 3.16, ‘Pertussis’).
Using adult/adolescent formulation dTpa vaccine
for boosters
The adult/adolescent formulation dTpa (Boostrix) is available for use in
Australia in those 8 years of age and older. However dTpa should not be used
for the primary immunisation of adolescents/adults against pertussis, and
therefore is not appropriate for catch-up immunisation.
A booster dose of adult/adolescent formulation dTpa on a single occasion
is recommended for the following groups. Once a booster dose of dTpa has
been given, subsequent booster doses to the same individual should not be
administered even if he/she qualifies for another of these groups:
- routine use at 15 to 17 years of age, replacing the dose of
ADT at 15 to 19 years of age in the ASVS;
- adults planning a pregnancy, or for both parents as soon as
possible after delivery of an infant;
- adults working with young children, in particular
health-care and child-care workers;
- adults at 50 years of age, as an alternative to the
recommended ADT.
(For further details on these recommendations, and on adult/adolescent
formulation dTpa see
Part 3.16, ‘Pertussis’). NB: Because data on the duration of immunity to
pertussis following adult/adolescent formulation dTpa are limited, no
recommendations on further doses of dTpa following an initial booster can be
given at this time.
Catch-up for Hib vaccines (for children under 5
years of age)
Hib vaccines should not be administered before 6 weeks of age. Hib
vaccines are not necessary after the fifth birthday, except for patients
with asplenia.
Tables 1.9.2 and
1.9.3 should be read together when determining the correct schedule.
Table 1.9.2: Recommended catch-up schedule when start
of Hib vaccination has been delayed
| Vaccine |
Trade name |
Age now |
| 3-6 months |
7-11 months |
12-14 months |
15-59 months |
| PRP-OMP (1), (2) |
PedvaxHIB |
2 doses, 1-2 months apart
and booster at 12 months |
2 doses, 1-2 months apart
and booster at least 2
months later, at 12-15 months |
1 dose, and booster at least 2
months after previous dose (4) |
Single dose (3) (4) |
| Hib (PRP-OMP)-hepB |
Comvax |
| HbOC (3) |
HibTITER |
3 doses, 2 months apart,
and booster at 12 months |
2 doses, 2 months apart,
and booster at 12 months
and at least 2 months after previous dose |
1 dose, and booster at 18
months |
Single dose (3) (4) |
| PRP-T (3) |
Hiberix
ActHIB |
| (1) Extremely preterm babies
(<28 weeks or <1500 grams) who commence catch-up Hib vaccination
with PRP-OMP between 3-11 months of age require a 3-dose primary
series (not 2 doses). The third dose should be given 1-2 months
after the second dose of PRP-OMP. The booster dose should be given
at 12 months as usual. |
| (2) Where possible, use the
same brand of Hib vaccine throughout the primary course. |
| (3) When a booster is given
after the age of 15 months, any of the 3 available conjugate Hib
vaccines can be used. |
| (4) Depending on the
combination used, further doses of hepatitis B or IPV are
required. |
|
Table 1.9.3: Recommendations for
Hib catch-up
vaccination when doses have been delayed or missed
| Age at presentation (months) |
Previous vaccination history |
Recommended regimen |
| 7 — 11 |
1 dose |
1 dose of Hib vaccine at 7 to 11 months,
and booster at least 2 months later, at 12-15 months (1) |
| 7 — 11 |
2 doses of PRP-OMP |
Give third dose of PRP-OMP at 12 months
and at least 2 months after previous dose |
| 7 — 14 |
2 doses of HbOC, PRP-T, unknown brand or
mixture of vaccine brands |
Give third dose 1 or more months after
second dose, and fourth dose at 18 months (1) |
| 12 —14 |
1 dose before 12 months |
2 additional doses of any registered Hib
vaccine, separated by 2 months |
| 15 — 59 |
Any incomplete schedule |
A single dose of any Hib vaccine |
| (1) Where possible, the same
brand of vaccine should be given for all doses. |
|
Catch-up for hepatitis B vaccines
The first dose of hepatitis B vaccine can be given as soon as possible
after birth (within 24 hours) and should be given within 7 days of birth.
The first dose should not be counted
as a valid dose if given after 7 days and before 8 weeks of age. Following
the birth dose, a total of 3 doses is required to achieve optimum protection
in infants and young children. Provided that the birth dose was administered
catch up doses of hepatitis B vaccine can be given one month apart.
Otherwise, ensure each child has a minimum interval of 4 weeks between the
first and second doses, and 2 months between the second and third doses (Table
1.9.1). A catch-up schedule may be completed with hepatitis B containing
combination vaccines or monovalent vaccines.
Different brands of hepatitis B vaccine, including the hepatitis B
component of multivalent vaccines such as DTPa-hepB and Hib (PRP-OMP)-hepB
can be used interchangeably throughout the schedule.
If using two dose schedules (see
Table 3.9.1), the minimum interval between doses of H-B-Vax II 10 µg for
11 to 15 year olds is 4 months, but is 6 months for 1 to 15 year olds when
using Twinrix (720/20).
Table 1.9.4:
Hepatitis B vaccine catch-up schedule
for adolescents aged 11 to 15 years
| Hepatitis B vaccine history |
Recommended catch-up schedule* |
| No previous doses |
Complete with 2 adult doses of H-B-Vax II,
4 to 6 months apart. |
| 1 dose of paediatric hepatitis B vaccine
(any brand) |
Complete with 2 doses of paediatric
hepatitis B vaccine (any brand). There should be a minimum
interval of one month between the first and second doses, and 2
months between the second and third. |
| 2 doses of paediatric hepatitis B vaccine
(any brand) |
Complete with 1 dose of paediatric
hepatitis B vaccine (any brand) at least 2 months after the
previous dose. |
| 1 dose of adult formulation of adult
H-B-Vax II |
Complete with 1 dose of adult H-B-Vax II
at 4 to 6 months after previous dose. |
| 2 doses of adult H-B-Vax II BUT with
interval of less than 4 months between doses |
Complete with 1 adult dose of H-B-Vax II
but at least 2 months after the previous dose. |
| *Only one monovalent hepatitis
B vaccine (H-B-Vax II 10 mg formulation) is approved for use in
Australia in a 2-dose schedule and only for adolescents aged 11-15
years. Catch-up for people aged 16-19 years must be administered
using a 3-dose paediatric formulation. |
|
Table 1.9.5:
Hepatitis B vaccine catch-up schedule
for adolescents aged 16 to 19 years*
| Hepatitis B vaccine history |
Recommended catch-up schedule* |
| No previous doses |
Start a 3-dose hepatitis B vaccine
schedule using paediatric formulation (any brand). Administer at
intervals of 0, 1 and 2-6 months |
| 1 dose of paediatric hepatitis B vaccine
(any brand) |
Complete with 2 doses of paediatric
hepatitis B vaccine (any brand). There should be a minimum
interval of one month between the first and second doses and 2
months between the second and third doses. |
| 2 doses of paediatric hepatitis B vaccine
(any brand) |
Complete with 1 dose of paediatric
hepatitis B vaccine (any brand) at least 2 months after the
previous dose. |
| 1 dose of adult formulation of adult
H-B-Vax II given before the 16th birthday |
Give either 1 dose of adult H-B-Vax II at
least 4 months after the previous dose, or two doses of any
paediatric hepatitis B vaccine at the recommended minimum
intervals. |
| *Only one monovalent hepatitis
B vaccine (H-B-Vax II 10 mg formulation) is approved for use in
Australia in a 2-dose schedule and only for adolescents aged 11-15
years. Catch-up for people aged 16-19 years must be administered
using a 3-dose paediatric formulation. |
|

Catch-up for OPV or IPV
If no previous documented doses of polio vaccine have been given,
commence a catch-up program preferably using IPV. Give 3 doses of IPV at
least 4 weeks apart. Although IPV and OPV can be used interchangeably, IPV
is now the preferred vaccine for all doses for catch-up. If the child is
less than 4 years of age, give the fourth booster dose at the fourth
birthday preferably as DTPa-IPV and ensure that it is administered at least
4 weeks after the third dose of polio vaccine.
Any unimmunised person at increased risk of the disease (eg. those
travelling to a country where wild polio disease is circulating) should be
informed that it takes 2 to 3 months before vaccines produce adequate
protection against all 3 polioviruses.
Catch-up for MMR vaccine
If no previous documented doses have been given, catch-up for MMR
consists of 2 doses, at least 4 weeks apart. If a single dose has been given
more than a month earlier, give one dose.
Catch-up for meningococcal C conjugate vaccine
Infants 2-3 months of age require 3 doses of meningococcal C conjugate
vaccine, with a minimum interval of 4 weeks between doses. Infants aged 4–11
months require 2 doses with a minimum interval of 4 weeks between doses.
Children aged 12 months and over, adolescents and adults, require a single
dose only.
Catch-up for pneumococcal conjugate vaccine
See
Part 3.18 ‘Pneumococcal infections’.
Catch-up for varicella-zoster vaccine
Children between 12 months and 13 years of age require one dose of
varicella-zoster vaccine. Adolescents 14 years and over, and adults require
2 doses of varicella-zoster vaccine, administered one to 2 months apart.
|